The medication works by activating both GIP and GLP-1 receptors, enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and reducing appetite
When to Talk to a Healthcare Professional Theres no need to suffer through fatigue, especially in the long term
By mimicking GLP-1 and GIP hormones, it helps manage blood sugar and suppress appetite, leading to substantial weight loss for many patients
Having specific eating disorder-related guidance around prescribing will be important, not just for people who work with eating disorders, but for general practitioners. She is also concerned that the rise of GLP-1s for the eating disorder patient population can, at times, be a negative cultural signal that being thin is the best, most healthy way to exist, which can also hurt recovery
Legal documents indicate the weekly injectable may cause long-term health conditions, including gastroparesis, bowel blockage, and vision disturbances
Show notes Today, we focus on three news pieces from last week that reminded us of other stories we covered during 2025